Skip to content

A Clinical Study Of Kansya Shalaka Agnikarma In Vatakantaka.

A Randomized Controlled Clinical Trial To Study The Effect Of Kansya Shalaka Agnikarma In Pain Management Of Vatakantaka With Special Reference To Plantar Fasciitis - NIL

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/01/100523
Enrollment
70
Registered
2026-01-08
Start date
Unknown
Completion date
Unknown
Last updated
2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M708- Other soft tissue disorders related to use, overuse and pressure

Interventions

None listed

Sponsors

Dr Nikita Lalasaheb Elajale
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1) Diagnose patients exhibiting signs and symptoms of Vatakantaka, such as ruk (stiffness) and vedana (pain). 2) Target patients aged 40 60 years, regardless of religion or caste.

Exclusion criteria

Exclusion criteria: 1) Uncontrolled diabetes, hypertension, HIV, cardiac disease, cancer, or TB. 2) Local skin infection at the Agnikarma site. 3) Calcaneal stress fracture. 4) Anarha (unsuitable candidates) of Agnikarma.

Design outcomes

Primary

MeasureTime frame
Reduction in heel pain intensity in patients of Vatakantaka after Kansya Shalaka AgnikarmaTimepoint: 7 days

Secondary

MeasureTime frame
Where the trial group stands in comparison with control groupTimepoint: 18 months

Countries

India

Contacts

Public ContactDr Nikita Lalasaheb Elajale

SMBT Ayurved College And Hospital

drsmitaaher52@gmail.com9764700610

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 7, 2026